Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03595865
Other study ID # TPLS2018G
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date June 1, 2020

Study information

Verified date July 2018
Source The Affiliated Hospital of Qingdao University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A 6-month, parallel-group study of the safety and efficacy of tafluprostin for Chinese patients with posttrabeculectomy residual primary angle-closure glaucoma or posttrabeculectomy residual primary open angle glaucoma.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
tafluprostin
Both patients in PACG and POAG groups will dose 1 time daily in each eye for 6months. Each eye will be preformed tafluprostin 0.0015% at 9 PM.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
wangdabo

Outcome

Type Measure Description Time frame Safety issue
Primary IOP The IOP will be measured at 1, 2, 3, 4, 5, and 6 month visit. All IOP measurements are to be performed at about the same time of day (at 9 AM at each visit). After topical anesthesia and conjunctiva sac stained byfluorescence, IOP was measured by Goldmann tonometer. The IOP value was the mean of 3 consecutive measurements. 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03338088 - Evaluation of Adherence to Clinical Treatment of Glaucoma N/A
Not yet recruiting NCT04007276 - The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Phase 4
Recruiting NCT03220490 - Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops N/A
Completed NCT05319470 - Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Recruiting NCT04178863 - CATS Tonometer IOP Reduction Latanoprost Verses Timolol Phase 4
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Recruiting NCT06369077 - How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? Phase 4